首页 > 最新文献

Annals of hepato-biliary-pancreatic surgery最新文献

英文 中文
Comparative analysis of postoperative outcomes of single-incision cholecystectomy: Propensity score matching of robotic surgery using the da Vinci SP system and da Vinci Xi system vs. laparoscopic surgery. 单切口胆囊切除术术后结果的比较分析:达芬奇SP系统和达芬奇Xi系统与腹腔镜手术机器人手术的倾向评分匹配。
IF 1.1 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-31 Epub Date: 2025-01-20 DOI: 10.14701/ahbps.24-198
Jeong-Ik Park, Yong-Kyu Chung, Young Min Lee, Chang Woo Nam, Yang Won Nah

Backgrounds/aims: We compared the postoperative outcomes of single-incision laparoscopic cholecystectomy (SILC) with those of single-incision robotic cholecystectomy (SIRC) using the da Vinci Xi and SP systems.

Methods: We retrospectively analyzed data from 206 patients who underwent these procedures by a single surgeon between August 2020 and April 2022. Propensity score matching was used to adjust for confounders and evaluate outcomes.

Results: SILC exhibited shorter operation times compared to SIRC with Xi and SP (44.9 ± 14.5 min vs. 55.3 ± 12.2 min vs. 55.2 ± 16.2 min, p < 0.001). SIRC with Xi had shorter docking times (6.2 ± 2.8 min vs. 10.3 ± 2.3 min, p < 0.001), while SIRC with SP demonstrated reduced console times (11.2 ± 2.4 min vs. 18.6 ± 8.0 min, p < 0.001). Pain scores and complications did not significantly differ between the groups.

Conclusions: Both SILC and SIRC showed comparable outcomes, with the SP system providing advantages such as reduced console time and fully articulated arms, likely reducing surgeon stress.

背景/目的:我们比较了单切口腹腔镜胆囊切除术(SILC)和单切口机器人胆囊切除术(SIRC)使用达芬奇Xi和SP系统的术后效果。方法:我们回顾性分析了2020年8月至2022年4月期间由一名外科医生接受这些手术的206例患者的数据。倾向评分匹配用于调整混杂因素和评估结果。结果:与Xi和SP的sic相比,SILC的手术时间更短(44.9±14.5 min vs. 55.3±12.2 min vs. 55.2±16.2 min, p < 0.001)。Xi组SIRC的对接时间较短(6.2±2.8 min vs. 10.3±2.3 min, p < 0.001),而SP组SIRC的对接时间较短(11.2±2.4 min vs. 18.6±8.0 min, p < 0.001)。两组间疼痛评分和并发症无显著差异。结论:SILC和SIRC均显示出类似的结果,SP系统具有诸如减少控制台时间和完全铰接式臂等优势,可能减少外科医生的压力。
{"title":"Comparative analysis of postoperative outcomes of single-incision cholecystectomy: Propensity score matching of robotic surgery using the da Vinci SP system and da Vinci Xi system vs. laparoscopic surgery.","authors":"Jeong-Ik Park, Yong-Kyu Chung, Young Min Lee, Chang Woo Nam, Yang Won Nah","doi":"10.14701/ahbps.24-198","DOIUrl":"10.14701/ahbps.24-198","url":null,"abstract":"<p><strong>Backgrounds/aims: </strong>We compared the postoperative outcomes of single-incision laparoscopic cholecystectomy (SILC) with those of single-incision robotic cholecystectomy (SIRC) using the da Vinci Xi and SP systems.</p><p><strong>Methods: </strong>We retrospectively analyzed data from 206 patients who underwent these procedures by a single surgeon between August 2020 and April 2022. Propensity score matching was used to adjust for confounders and evaluate outcomes.</p><p><strong>Results: </strong>SILC exhibited shorter operation times compared to SIRC with Xi and SP (44.9 ± 14.5 min vs. 55.3 ± 12.2 min vs. 55.2 ± 16.2 min, <i>p</i> < 0.001). SIRC with Xi had shorter docking times (6.2 ± 2.8 min vs. 10.3 ± 2.3 min, <i>p</i> < 0.001), while SIRC with SP demonstrated reduced console times (11.2 ± 2.4 min vs. 18.6 ± 8.0 min, <i>p</i> < 0.001). Pain scores and complications did not significantly differ between the groups.</p><p><strong>Conclusions: </strong>Both SILC and SIRC showed comparable outcomes, with the SP system providing advantages such as reduced console time and fully articulated arms, likely reducing surgeon stress.</p>","PeriodicalId":72220,"journal":{"name":"Annals of hepato-biliary-pancreatic surgery","volume":" ","pages":"140-149"},"PeriodicalIF":1.1,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12093242/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143017332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
"Liver-loop": A case report of an alternative modified liver hanging maneuver. "肝循环":另一种改良肝脏悬吊术的病例报告。
IF 1.1 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-31 Epub Date: 2025-02-18 DOI: 10.14701/ahbps.24-217
Rodrigo Antonio Gasque, José Gabriel Cervantes, Magalí Chahdi Beltrame, Marcelo Enrique Lenz Virreira, Francisco Juan Mattera, Emilio Gastón Quiñonez

The liver hanging maneuver (LHM), introduced by Belghiti et al. in 2001, has been widely adapted to various hepatectomy techniques to reduce blood loss and facilitate parenchymal transection. However, its primary limitation is the risk of vascular injury, particularly near the inferior vena cava (IVC). In this report, we describe a modified "Loop-Hanging" maneuver designed as an alternative to enhance exposure during parenchymal transection and improve the control of Glissonean pedicles. In this case, we employed the technique during an open right hemihepatectomy on a 47-year-old male patient with a complex bile duct injury following two unsuccessful Roux-en-Y hepaticojejunostomies (RYHJ). The patient was referred to our institution due to an RYHJ stricture. Imaging identified a right hepatic artery pseudoaneurysm and a fistula to the biliary limb. After two failed attempts at endovascular embolization, a surgical approach was determined through multidisciplinary discussions. During the surgery, the liver was looped with a nasogastric tube positioned anterior to the IVC, allowing gentle upward traction that facilitated the transection, minimized bleeding, and enhanced pedicle control. The LHM is known to reduce blood loss but carries risks for patients with anatomical variations, scarring, or cirrhosis. Our "Loop-Hanging" technique retains the core advantages of LHM, simplifies the process, and diminishes the risk of vascular injury. Further research is required to assess its safety and broader applicability.

由Belghiti等人于2001年提出的肝悬挂术(liver hanging maneuver, LHM)已被广泛应用于各种肝切除术技术,以减少出血量并促进实质横断。然而,其主要限制是血管损伤的风险,特别是下腔静脉(IVC)附近。在本报告中,我们描述了一种改良的“环挂”操作,设计为一种替代方案,以增强实质横断时的暴露,并改善对Glissonean蒂的控制。在本病例中,我们对一名47岁男性患者进行了开放的右半肝切除术,该患者在两次Roux-en-Y肝空肠吻合术(RYHJ)失败后出现了复杂的胆管损伤。患者因RYHJ结构被转介到我们的机构。影像学检查发现右肝动脉假性动脉瘤和胆道肢瘘管。在两次血管内栓塞失败后,通过多学科讨论确定了手术方法。在手术过程中,将位于下腔静脉前方的鼻胃管环绕肝脏,允许温和的向上牵引,促进横切,减少出血,并加强蒂控制。已知LHM可以减少失血量,但对解剖变异、疤痕或肝硬化患者有风险。我们的“环挂”技术保留了LHM的核心优势,简化了过程,降低了血管损伤的风险。需要进一步的研究来评估其安全性和更广泛的适用性。
{"title":"\"Liver-loop\": A case report of an alternative modified liver hanging maneuver.","authors":"Rodrigo Antonio Gasque, José Gabriel Cervantes, Magalí Chahdi Beltrame, Marcelo Enrique Lenz Virreira, Francisco Juan Mattera, Emilio Gastón Quiñonez","doi":"10.14701/ahbps.24-217","DOIUrl":"10.14701/ahbps.24-217","url":null,"abstract":"<p><p>The liver hanging maneuver (LHM), introduced by Belghiti et al. in 2001, has been widely adapted to various hepatectomy techniques to reduce blood loss and facilitate parenchymal transection. However, its primary limitation is the risk of vascular injury, particularly near the inferior vena cava (IVC). In this report, we describe a modified \"Loop-Hanging\" maneuver designed as an alternative to enhance exposure during parenchymal transection and improve the control of Glissonean pedicles. In this case, we employed the technique during an open right hemihepatectomy on a 47-year-old male patient with a complex bile duct injury following two unsuccessful Roux-en-Y hepaticojejunostomies (RYHJ). The patient was referred to our institution due to an RYHJ stricture. Imaging identified a right hepatic artery pseudoaneurysm and a fistula to the biliary limb. After two failed attempts at endovascular embolization, a surgical approach was determined through multidisciplinary discussions. During the surgery, the liver was looped with a nasogastric tube positioned anterior to the IVC, allowing gentle upward traction that facilitated the transection, minimized bleeding, and enhanced pedicle control. The LHM is known to reduce blood loss but carries risks for patients with anatomical variations, scarring, or cirrhosis. Our \"Loop-Hanging\" technique retains the core advantages of LHM, simplifies the process, and diminishes the risk of vascular injury. Further research is required to assess its safety and broader applicability.</p>","PeriodicalId":72220,"journal":{"name":"Annals of hepato-biliary-pancreatic surgery","volume":" ","pages":"187-191"},"PeriodicalIF":1.1,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12093238/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143443004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Parenchymal-sparing non-anatomic resection vs. classic anatomic resection in colorectal cancer liver metastases. 保留肝实质的非解剖切除与经典解剖切除在结直肠癌肝转移中的比较。
IF 1.1 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-31 Epub Date: 2025-02-18 DOI: 10.14701/ahbps.24-151
Sungwon Jung

Backgrounds/aims: Although anatomical liver resection is considered more effective in preventing complications and recurrence in hepatocellular carcinoma, its efficacy has yet to be clearly defined in colorectal cancer liver metastasis (CLM).

Methods: From January 2000 to December 2023, 145 patients underwent liver resections for CLM, divided into anatomic and non-anatomic resection cohorts. The dataset included demographic details, tumor size, number and distribution of metastases, neoadjuvant chemotherapy, primary tumor location and stage, type of liver surgery, transfusion rates, duration of hospital stay, postoperative complications, and completeness of resection.

Results: Of the 145 patients who underwent liver resections for metastases from colorectal cancer, 62 were in the anatomic group and 83 were in the non-anatomic group. The anatomic group had larger tumors (6.71 cm vs. 3.18 cm). Intraoperative transfusion rates were higher in the anatomic group (56.5% vs. 12.0%). Hospital stays, positive resection margin rates, and postoperative complication rates showed no significant differences. One surgery-related death occurred in the anatomic group. Disease-free and overall survival rates were comparable between groups.

Conclusions: Anatomic liver resection did not demonstrate a reduction in recurrence or an improvement in survival rates compared to non-anatomic resection. As such, anatomical resection does not offer a survival advantage over non-anatomical resection. Consequently, surgical method selection should prioritize patient safety, preservation of residual liver parenchyma, and tumor-specific factors.

背景/目的:虽然解剖性肝切除术被认为在预防肝细胞癌并发症和复发方面更有效,但其在结直肠癌肝转移(CLM)中的疗效尚未明确。方法:2000年1月至2023年12月,145例CLM患者行肝切除术,分为解剖和非解剖两组。数据集包括人口统计学细节、肿瘤大小、转移的数量和分布、新辅助化疗、原发肿瘤的位置和分期、肝脏手术类型、输血率、住院时间、术后并发症和切除的完整性。结果:145例结直肠癌转移肝切除术患者中,解剖组62例,非解剖组83例。解剖组肿瘤较大(6.71 cm vs. 3.18 cm)。解剖组术中输血率较高(56.5%比12.0%)。住院时间、阳性切缘率和术后并发症发生率无显著差异。解剖组发生一例手术相关死亡。两组间无病生存率和总生存率具有可比性。结论:与非解剖性肝切除术相比,解剖性肝切除术并没有减少复发或提高生存率。因此,解剖切除并不比非解剖切除提供生存优势。因此,手术方法的选择应优先考虑患者安全、保留残余肝实质和肿瘤特异性因素。
{"title":"Parenchymal-sparing non-anatomic resection vs. classic anatomic resection in colorectal cancer liver metastases.","authors":"Sungwon Jung","doi":"10.14701/ahbps.24-151","DOIUrl":"10.14701/ahbps.24-151","url":null,"abstract":"<p><strong>Backgrounds/aims: </strong>Although anatomical liver resection is considered more effective in preventing complications and recurrence in hepatocellular carcinoma, its efficacy has yet to be clearly defined in colorectal cancer liver metastasis (CLM).</p><p><strong>Methods: </strong>From January 2000 to December 2023, 145 patients underwent liver resections for CLM, divided into anatomic and non-anatomic resection cohorts. The dataset included demographic details, tumor size, number and distribution of metastases, neoadjuvant chemotherapy, primary tumor location and stage, type of liver surgery, transfusion rates, duration of hospital stay, postoperative complications, and completeness of resection.</p><p><strong>Results: </strong>Of the 145 patients who underwent liver resections for metastases from colorectal cancer, 62 were in the anatomic group and 83 were in the non-anatomic group. The anatomic group had larger tumors (6.71 cm vs. 3.18 cm). Intraoperative transfusion rates were higher in the anatomic group (56.5% vs. 12.0%). Hospital stays, positive resection margin rates, and postoperative complication rates showed no significant differences. One surgery-related death occurred in the anatomic group. Disease-free and overall survival rates were comparable between groups.</p><p><strong>Conclusions: </strong>Anatomic liver resection did not demonstrate a reduction in recurrence or an improvement in survival rates compared to non-anatomic resection. As such, anatomical resection does not offer a <i>survival</i> advantage over non-anatomical resection. Consequently, surgical method selection should prioritize patient safety, preservation of residual liver parenchyma, and tumor-specific factors.</p>","PeriodicalId":72220,"journal":{"name":"Annals of hepato-biliary-pancreatic surgery","volume":" ","pages":"121-126"},"PeriodicalIF":1.1,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12093235/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143441862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcome after spleen-preserving distal pancreatectomy by Warshaw technique for pancreatic body cancer. Warshaw技术保脾胰远端切除术治疗胰小体癌的疗效观察。
IF 1.1 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-31 Epub Date: 2025-03-24 DOI: 10.14701/ahbps.24-202
Endi Zhou, Guodong Shi, Hongyuan Shi, Kai Zhang, Jishu Wei, Min Tu, Zipeng Lu, Feng Guo, Jianmin Chen, Kuirong Jiang, Wentao Gao

Backgrounds/aims: Distal pancreatectomy with splenectomy (DPS) is a common surgical procedure for pancreatic body cancer. However, spleen-preserving distal pancreatectomy (SPDP) utilizing the Warshaw technique (WT) in malignancies is generally not favored due to concerns about inadequate resection. This study aims to assess the feasibility and oncologic outcomes of employing SPDP with WT in pancreatic body cancer.

Methods: We conducted a retrospective analysis comparing 21 SPDP patients with 63 DPS patients matched by propensity score from January 2018 to November 2022. Clinical outcomes and follow-up data were analyzed using R.

Results: Both groups exhibited similar demographic, intraoperative, and pathological characteristics, with the exception of a reduced number of total lymph nodes (p = 0.006) in the SPDP group. There were no significant differences in the rates of postoperative complications, recurrence, or metastasis. Local recurrence predominantly occurred in the central region as opposed to the spleen region. There were no cases of isolated recurrences in the splenic region. Median overall survival and recurrence-free survival times were 51.5 months for SPDP vs 30.5 months for DPS and 18.7 months vs 16.8 months, respectively (p > 0.05). The incidence of partial splenic infarction and left-side portal hypertension in the SPDP group was 28.6% (6/21) and 9.5% (2/21), respectively, without necessitating splenic abscess puncture, splenectomy, or causing bleeding from perigastric varices.

Conclusions: SPDP did not negatively impact local recurrence or survival rates in selected pancreatic body cancer patients. Further studies are necessary for validation.

背景/目的:远端胰腺切除术联合脾切除术(DPS)是治疗胰腺体癌的常用手术方式。然而,由于担心切除不充分,在恶性肿瘤中使用Warshaw技术(WT)的保脾远端胰腺切除术(SPDP)通常不受欢迎。本研究旨在评估应用SPDP联合WT治疗胰腺体癌的可行性和肿瘤学结果。方法:我们对2018年1月至2022年11月期间21例SPDP患者和63例DPS患者进行回顾性分析,并进行倾向评分匹配。结果:两组患者的人口学特征、术中特征和病理特征相似,但SPDP组总淋巴结数减少(p = 0.006)。两组在术后并发症、复发或转移率方面无显著差异。局部复发主要发生在中央区域,而不是脾脏区域。脾区无孤立性复发病例。SPDP患者的中位总生存期和无复发生存期分别为51.5个月和30.5个月,分别为18.7个月和16.8个月(p < 0.05)。SPDP组部分性脾梗死和左侧门静脉高压症的发生率分别为28.6%(6/21)和9.5%(2/21),不需要脾脓肿穿刺、脾切除术或引起胃周静脉曲张出血。结论:在选定的胰腺体癌患者中,SPDP对局部复发率或生存率没有负面影响。需要进一步的研究来验证。
{"title":"Outcome after spleen-preserving distal pancreatectomy by Warshaw technique for pancreatic body cancer.","authors":"Endi Zhou, Guodong Shi, Hongyuan Shi, Kai Zhang, Jishu Wei, Min Tu, Zipeng Lu, Feng Guo, Jianmin Chen, Kuirong Jiang, Wentao Gao","doi":"10.14701/ahbps.24-202","DOIUrl":"10.14701/ahbps.24-202","url":null,"abstract":"<p><strong>Backgrounds/aims: </strong>Distal pancreatectomy with splenectomy (DPS) is a common surgical procedure for pancreatic body cancer. However, spleen-preserving distal pancreatectomy (SPDP) utilizing the Warshaw technique (WT) in malignancies is generally not favored due to concerns about inadequate resection. This study aims to assess the feasibility and oncologic outcomes of employing SPDP with WT in pancreatic body cancer.</p><p><strong>Methods: </strong>We conducted a retrospective analysis comparing 21 SPDP patients with 63 DPS patients matched by propensity score from January 2018 to November 2022. Clinical outcomes and follow-up data were analyzed using R.</p><p><strong>Results: </strong>Both groups exhibited similar demographic, intraoperative, and pathological characteristics, with the exception of a reduced number of total lymph nodes (<i>p</i> = 0.006) in the SPDP group. There were no significant differences in the rates of postoperative complications, recurrence, or metastasis. Local recurrence predominantly occurred in the central region as opposed to the spleen region. There were no cases of isolated recurrences in the splenic region. Median overall survival and recurrence-free survival times were 51.5 months for SPDP vs 30.5 months for DPS and 18.7 months vs 16.8 months, respectively (<i>p</i> > 0.05). The incidence of partial splenic infarction and left-side portal hypertension in the SPDP group was 28.6% (6/21) and 9.5% (2/21), respectively, without necessitating splenic abscess puncture, splenectomy, or causing bleeding from perigastric varices.</p><p><strong>Conclusions: </strong>SPDP did not negatively impact local recurrence or survival rates in selected pancreatic body cancer patients. Further studies are necessary for validation.</p>","PeriodicalId":72220,"journal":{"name":"Annals of hepato-biliary-pancreatic surgery","volume":" ","pages":"177-186"},"PeriodicalIF":1.1,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12093236/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143694628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is it time to define the scope of safety for robotic resection in perihilar cholangiocarcinoma surgery? A propensity score matching based analysis of a single center experience. 在肝门周围胆管癌手术中,是时候确定机器人切除的安全范围了吗?基于单中心经验的倾向评分匹配分析。
IF 1.1 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-31 Epub Date: 2025-04-15 DOI: 10.14701/ahbps.25-012
Mikhail Efanov, Pavel Tarakanov, Yuliya Kulezneva, Olga Melekhina, Anna Koroleva, Andrey Vankovich, Dmitry Kovalenko, Denis Fisenko, Victor Tsvirkun, Igor Khatkov

Backgrounds/aims: Robotic surgery for perihilar cholangiocarcinoma is in the developmental and exploratory phase. The objective of this study was to compare the short-term outcomes and survival rates of robotic versus open resection for perihilar cholangiocarcinoma in a single center, and to determine the reliable scope of robotic interventions.

Methods: A comparative analysis of outcomes from open and robotic resections at a single center was conducted using propensity score matching (PSM). The balance of covariates was assessed using standardized mean differences, and the robotic resection procedures adhered to the standards of open surgery.

Results: PSM was effectively applied between 41 robotic and 82 open resections. No differences were observed in blood loss, overall and severe morbidity, 90-day mortality, or length of hospital stay. Robotic resections were longer but resulted in better immediate oncological outcomes. Median overall survival for the robotic and open groups was 44 and 30 months (p = 0.259) before PSM and 44 and 29 months (p = 0.164) after PSM respectively. Conversion was required in 8 cases. A subgroup analysis excluding conversions revealed no differences in immediate and long-term outcomes. All patients undergoing robotic resection for Bismuth types I and II were alive at a mean follow-up of 37 months.

Conclusions: The robotic approach is comparable to open resection regarding immediate outcomes and survival in select patients with perihilar cholangiocarcinoma. For patients with Bismuth type I and II tumors and early (stages I and II) TNM stages, robotic resection is a reliable treatment option when aligned with the principles of open surgery.

背景/目的:机器人手术治疗肝门周围胆管癌尚处于发展和探索阶段。本研究的目的是比较单中心机器人与开放切除治疗肝门周围胆管癌的短期预后和生存率,并确定机器人干预的可靠范围。方法:采用倾向评分匹配(PSM)对单中心开放式和机器人切除的结果进行比较分析。使用标准化平均差评估协变量的平衡,机器人切除手术遵循开放手术的标准。结果:PSM有效应用于41例机器人手术和82例开放手术。在出血量、总体和严重发病率、90天死亡率或住院时间方面没有观察到差异。机器人切除的时间更长,但效果更好。机器人组和开放组的中位总生存期分别为PSM前44个月和30个月(p = 0.259), PSM后44个月和29个月(p = 0.164)。有8例需要转诊。排除转归的亚组分析显示,近期和长期结果没有差异。所有接受机器人切除I型和II型铋的患者在平均随访37个月时仍然存活。结论:在选择肝门周围胆管癌患者的即时预后和生存率方面,机器人入路与开放切除相当。对于Bismuth I型和II型肿瘤以及早期(I期和II期)TNM患者,在符合开放手术原则的情况下,机器人切除是一种可靠的治疗选择。
{"title":"Is it time to define the scope of safety for robotic resection in perihilar cholangiocarcinoma surgery? A propensity score matching based analysis of a single center experience.","authors":"Mikhail Efanov, Pavel Tarakanov, Yuliya Kulezneva, Olga Melekhina, Anna Koroleva, Andrey Vankovich, Dmitry Kovalenko, Denis Fisenko, Victor Tsvirkun, Igor Khatkov","doi":"10.14701/ahbps.25-012","DOIUrl":"10.14701/ahbps.25-012","url":null,"abstract":"<p><strong>Backgrounds/aims: </strong>Robotic surgery for perihilar cholangiocarcinoma is in the developmental and exploratory phase. The objective of this study was to compare the short-term outcomes and survival rates of robotic versus open resection for perihilar cholangiocarcinoma in a single center, and to determine the reliable scope of robotic interventions.</p><p><strong>Methods: </strong>A comparative analysis of outcomes from open and robotic resections at a single center was conducted using propensity score matching (PSM). The balance of covariates was assessed using standardized mean differences, and the robotic resection procedures adhered to the standards of open surgery.</p><p><strong>Results: </strong>PSM was effectively applied between 41 robotic and 82 open resections. No differences were observed in blood loss, overall and severe morbidity, 90-day mortality, or length of hospital stay. Robotic resections were longer but resulted in better immediate oncological outcomes. Median overall survival for the robotic and open groups was 44 and 30 months (<i>p</i> = 0.259) before PSM and 44 and 29 months (<i>p</i> = 0.164) after PSM respectively. Conversion was required in 8 cases. A subgroup analysis excluding conversions revealed no differences in immediate and long-term outcomes. All patients undergoing robotic resection for Bismuth types I and II were alive at a mean follow-up of 37 months.</p><p><strong>Conclusions: </strong>The robotic approach is comparable to open resection regarding immediate outcomes and survival in select patients with perihilar cholangiocarcinoma. For patients with Bismuth type I and II tumors and early (stages I and II) TNM stages, robotic resection is a reliable treatment option when aligned with the principles of open surgery.</p>","PeriodicalId":72220,"journal":{"name":"Annals of hepato-biliary-pancreatic surgery","volume":"29 2","pages":"127-139"},"PeriodicalIF":1.1,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12093234/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143998959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heterotopic pancreas of the gallbladder: A case report of a rare and commonly incidental finding. 胆囊异位胰腺:一个罕见的和通常偶然发现的病例报告。
IF 1.1 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-31 Epub Date: 2025-01-13 DOI: 10.14701/ahbps.24-190
Nelson Chen, Jessica Gu

Heterotopic pancreas (HP) refers to the presence of ectopic pancreatic tissue located outside of the normal pancreatic location without anatomical or vascular continuity with the pancreas. HP within the gallbladder (HPGB) was first described by Otschkin in 1916. It remains an exceedingly rare pathology with few reported cases. Here we describe a case of HPGB in a 42-year-old female following laparoscopic cholecystectomy for symptoms of biliary colic. She presented with epigastric pain, elevated levels in liver function tests, and gallbladder sludge on ultrasound. Her lipase and bilirubin levels were within normal limits. Histopathological assessment of the gallbladder identified mild chronic cholecystitis and pancreatic heterotopia adjacent to the cystic duct of the gallbladder with all three elements (ducts, acini, and endocrine islets) of the pancreas, consistent with type 1 based on the classification of Gaspar Fuentes et al. HPGB is often diagnosed incidentally during histopathological examination after cholecystectomy. Preoperative diagnosis is challenging due to its rarity. It is thought to be asymptomatic. Although the clinical significance of HPGB remains uncertain, it has been hypothesized that HPGB can cause acalculous cholecystitis and also have the potential for malignant transformation. Our case supports the theory that the exocrine function of an ectopic pancreatic tissue may contribute to chronic inflammation in the gallbladder. In conclusion, although HPGB is a rare finding with unclear clinical relevance, its potential for malignancy and association with cholecystitis warrant further investigation. Given its scarcity, most knowledge about HPGB comes from case reports and case series. This report adds to the existing literature.

异位胰腺(HP)是指位于正常胰腺位置之外的异位胰腺组织与胰腺没有解剖或血管连续性。1916年,Otschkin首次描述了胆囊内HP (HPGB)。它仍然是一种极其罕见的病理,报告的病例很少。我们在此报告一例42岁女性因胆绞痛症状行腹腔镜胆囊切除术后的HPGB病例。她表现为胃脘痛,肝功能检查水平升高,超声显示胆囊淤积。她的脂肪酶和胆红素水平在正常范围内。胆囊的组织病理学评估发现轻度慢性胆囊炎和胆囊胆囊管附近的胰腺异位,并伴有胰腺的所有三种成分(导管、腺泡和内分泌胰岛),根据Gaspar Fuentes等人的分类,符合1型。HPGB常在胆囊切除术后的组织病理学检查中偶然发现。由于罕见,术前诊断具有挑战性。它被认为是无症状的。虽然HPGB的临床意义尚不确定,但已有假设HPGB可引起无结石性胆囊炎,也有恶性转化的可能。本病例支持异位胰腺组织的外分泌功能可能导致胆囊慢性炎症的理论。总之,尽管HPGB是一种罕见的发现,临床相关性不明确,但其潜在的恶性肿瘤及其与胆囊炎的关系值得进一步研究。鉴于其稀缺性,大多数关于HPGB的知识来自病例报告和病例系列。这份报告补充了现有的文献。
{"title":"Heterotopic pancreas of the gallbladder: A case report of a rare and commonly incidental finding.","authors":"Nelson Chen, Jessica Gu","doi":"10.14701/ahbps.24-190","DOIUrl":"10.14701/ahbps.24-190","url":null,"abstract":"<p><p>Heterotopic pancreas (HP) refers to the presence of ectopic pancreatic tissue located outside of the normal pancreatic location without anatomical or vascular continuity with the pancreas. HP within the gallbladder (HPGB) was first described by Otschkin in 1916. It remains an exceedingly rare pathology with few reported cases. Here we describe a case of HPGB in a 42-year-old female following laparoscopic cholecystectomy for symptoms of biliary colic. She presented with epigastric pain, elevated levels in liver function tests, and gallbladder sludge on ultrasound. Her lipase and bilirubin levels were within normal limits. Histopathological assessment of the gallbladder identified mild chronic cholecystitis and pancreatic heterotopia adjacent to the cystic duct of the gallbladder with all three elements (ducts, acini, and endocrine islets) of the pancreas, consistent with type 1 based on the classification of Gaspar Fuentes et al. HPGB is often diagnosed incidentally during histopathological examination after cholecystectomy. Preoperative diagnosis is challenging due to its rarity. It is thought to be asymptomatic. Although the clinical significance of HPGB remains uncertain, it has been hypothesized that HPGB can cause acalculous cholecystitis and also have the potential for malignant transformation. Our case supports the theory that the exocrine function of an ectopic pancreatic tissue may contribute to chronic inflammation in the gallbladder. In conclusion, although HPGB is a rare finding with unclear clinical relevance, its potential for malignancy and association with cholecystitis warrant further investigation. Given its scarcity, most knowledge about HPGB comes from case reports and case series. This report adds to the existing literature.</p>","PeriodicalId":72220,"journal":{"name":"Annals of hepato-biliary-pancreatic surgery","volume":" ","pages":"205-208"},"PeriodicalIF":1.1,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12093241/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142973612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility and safety of robotic radical resection for hilar cholangiocarcinoma in highly selected patients: A systematic review and meta-analysis with meta-regression. 机器人根治术治疗高选择性患者肝门胆管癌的可行性和安全性:一项系统综述和荟萃分析。
IF 1.1 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-31 Epub Date: 2025-02-26 DOI: 10.14701/ahbps.24-236
Shahab Hajibandeh, Shahin Hajibandeh, Thomas Satyadas

To examine the feasibility and safety of robotic radical resection (RRR) for hilar cholangiocarcinoma (HCCA). A PRISMA-compliant meta-analysis with meta-regression was conducted, including studies reporting outcomes of RRR in patients with HCCA. Six studies comprising 295 patients were included. In highly selected patients (body mass index [BMI] < 25 kg/m" ; tumor size < 3 cm), RRR of HCCA proved safe and feasible (Clavien-Dindo ≥ III complications: 14.8% [95% confidence interval 8.7%-20.8%]; 30-day mortality: 1.9% [0%-4.2%]; conversion to open surgery: 1.9% [0%-4.2%]; intraoperative blood loss: 210 mL [119-301 mL]; operative time: 481 minutes [339-623 minutes]; R0 resection rate: 82.2% [75.0%-89.4%]; retrieved lymph nodes: 12 [9-16]). Younger age (p = 0.008), higher BMI (p = 0.009), larger tumors (p = 0.048), and performing liver resections (p = 0.017) increased blood loss. American Society of Anesthesiologists status ≥ III (p < 0.001) and Bismuth IV disease (p < 0.001) increased operative times. Preoperative biliary drainage (p = 0.027) enhanced R0 resection rates. RRR led to less bleeding (mean difference [MD]: -184 mL, p = 0.0005), longer operative times (MD: 162 minutes, p = 0.001), and improved R0 resection rates (odds ratio: 3.29, p = 0.006) compared with the open approach. Subject to selection bias and type 2 error, RRR for HCCA might be safe and feasible in highly selected patients (favorable BMI and tumor size). The findings should not be taken as definitive conclusions but may be used for hypothesis generation in subsequent trials.

目的探讨机器人根治术治疗肝门胆管癌(HCCA)的可行性和安全性。进行了符合prisma标准的荟萃分析和meta回归,包括报告HCCA患者RRR结果的研究。包括295名患者的6项研究。在高度选定的患者(体重指数[BMI] < 25 kg/m);肿瘤大小< 3cm), HCCA的RRR被证明是安全可行的(Clavien-Dindo≥III并发症:14.8%[95%可信区间8.7%-20.8%];30天死亡率:1.9% [0%-4.2%];转开腹手术:1.9% [0%-4.2%];术中出血量:210 mL [119 ~ 301 mL];手术时间:481分钟[339 ~ 623分钟];R0切除率:82.2% [75.0% ~ 89.4%];淋巴结:12[9-16])。年龄越小(p = 0.008)、BMI越高(p = 0.009)、肿瘤越大(p = 0.048)和肝切除(p = 0.017)会增加失血量。美国麻醉医师协会状态≥III (p < 0.001)和Bismuth IV疾病(p < 0.001)增加手术次数。术前胆道引流(p = 0.027)可提高R0切除率。与开放入路相比,RRR导致出血减少(平均差[MD]: -184 mL, p = 0.0005),手术时间延长(MD: 162分钟,p = 0.001), R0切除率提高(优势比:3.29,p = 0.006)。受选择偏倚和2型误差的影响,HCCA的RRR在高选择性患者(有利的BMI和肿瘤大小)中可能是安全可行的。这些发现不应被视为确定的结论,但可用于后续试验中的假设生成。
{"title":"Feasibility and safety of robotic radical resection for hilar cholangiocarcinoma in highly selected patients: A systematic review and meta-analysis with meta-regression.","authors":"Shahab Hajibandeh, Shahin Hajibandeh, Thomas Satyadas","doi":"10.14701/ahbps.24-236","DOIUrl":"10.14701/ahbps.24-236","url":null,"abstract":"<p><p>To examine the feasibility and safety of robotic radical resection (RRR) for hilar cholangiocarcinoma (HCCA). A PRISMA-compliant meta-analysis with meta-regression was conducted, including studies reporting outcomes of RRR in patients with HCCA. Six studies comprising 295 patients were included. In highly selected patients (body mass index [BMI] < 25 kg/m\" ; tumor size < 3 cm), RRR of HCCA proved safe and feasible (Clavien-Dindo ≥ III complications: 14.8% [95% confidence interval 8.7%-20.8%]; 30-day mortality: 1.9% [0%-4.2%]; conversion to open surgery: 1.9% [0%-4.2%]; intraoperative blood loss: 210 mL [119-301 mL]; operative time: 481 minutes [339-623 minutes]; R0 resection rate: 82.2% [75.0%-89.4%]; retrieved lymph nodes: 12 [9-16]). Younger age (<i>p</i> = 0.008), higher BMI (<i>p</i> = 0.009), larger tumors (<i>p</i> = 0.048), and performing liver resections (<i>p</i> = 0.017) increased blood loss. American Society of Anesthesiologists status ≥ III (<i>p</i> < 0.001) and Bismuth IV disease (<i>p</i> < 0.001) increased operative times. Preoperative biliary drainage (<i>p</i> = 0.027) enhanced R0 resection rates. RRR led to less bleeding (mean difference [MD]: -184 mL, <i>p</i> = 0.0005), longer operative times (MD: 162 minutes, <i>p</i> = 0.001), and improved R0 resection rates (odds ratio: 3.29, <i>p</i> = 0.006) compared with the open approach. Subject to selection bias and type 2 error, RRR for HCCA might be safe and feasible in highly selected patients (favorable BMI and tumor size). The findings should not be taken as definitive conclusions but may be used for hypothesis generation in subsequent trials.</p>","PeriodicalId":72220,"journal":{"name":"Annals of hepato-biliary-pancreatic surgery","volume":" ","pages":"99-112"},"PeriodicalIF":1.1,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12093240/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143505990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From the operating room: Surgeons' views on difficult laparoscopic cholecystectomies. 从手术室看:外科医生对腹腔镜胆囊切除术难度的看法。
IF 1.1 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-31 Epub Date: 2025-02-26 DOI: 10.14701/ahbps.24-219
Ritika Agarwal, Vinay M D Prabhu, Nitin A R Rao

Backgrounds/aims: Assessing surgical difficulty in laparoscopic cholecystectomy (LC) is challenging due to variations in surgeon proficiency and institutional protocols. This study evaluates surgeons' perspectives on procedural difficulty and examines how intraoperative findings and preoperative imaging contribute to refining difficulty assessment criteria.

Methods: A cross-sectional survey was conducted among 50 laparoscopic surgeons in India, providing insights into tolerances for surgical duration and blood loss, reasons for conversion, and predictors of complexity. Responses were analyzed using SPSS, with statistical significance set at p < 0.05.

Results: Among surveyed surgeons, 82.0% were male, and 78.0% worked in private institutions and 52.0% had performed over 1,000 LCs. Conversion to open surgery was primarily influenced by significant blood loss (68.0%) and biliary injury (94.0%). While 38.0% preferred surgeries under 60 minutes, 26.0% imposed no time constraints. Key intraoperative challenges included dense adhesions, cholecysto-enteric fistulas, and fibrosis. Less experienced surgeons reported greater challenges with scarring adhesions and anatomical variations, but no significant differences were found for other factors like edematous or necrotic changes. Preoperative imaging was considered essential by most surgeons.

Conclusions: This study underscores the limited reliability of traditional parameters for assessing difficulty in LC. Surgeons highlighted the importance of objective intraoperative findings and preoperative imaging in predicting surgical challenges. Factors such as adhesions, fibrosis, and anatomical variations significantly impact LC difficulty, with decisions regarding conversion to open surgery largely driven by individual judgment rather than experience. Standardized grading systems incorporating these factors could improve surgical planning, reduce complications, and enhance patient outcomes.

背景/目的:评估腹腔镜胆囊切除术(LC)的手术难度是具有挑战性的,由于外科医生的熟练程度和机构协议的变化。本研究评估了外科医生对手术难度的看法,并探讨了术中发现和术前成像如何有助于完善难度评估标准。方法:对印度50名腹腔镜外科医生进行横断面调查,提供对手术时间和出血量的耐受性、转换原因和复杂性预测因素的见解。采用SPSS统计分析,差异有统计学意义,p < 0.05。结果:受访外科医生中,男性占82.0%,78.0%在私立医疗机构工作,52.0%手术次数超过1000次。转向开腹手术的主要影响因素是大量失血(68.0%)和胆道损伤(94.0%)。而38.0%的人喜欢在60分钟内手术,26.0%的人没有时间限制。术中主要的挑战包括致密粘连、胆囊肠瘘和纤维化。经验不足的外科医生报告瘢痕性粘连和解剖变异的挑战更大,但在水肿或坏死变化等其他因素上没有发现显著差异。术前成像被大多数外科医生认为是必要的。结论:本研究强调了评估LC难度的传统参数的有限可靠性。外科医生强调了客观术中发现和术前影像学对预测手术挑战的重要性。诸如粘连、纤维化和解剖变异等因素显著影响LC难度,是否转换为开放手术主要取决于个人判断而非经验。纳入这些因素的标准化分级系统可以改善手术计划,减少并发症,提高患者预后。
{"title":"From the operating room: Surgeons' views on difficult laparoscopic cholecystectomies.","authors":"Ritika Agarwal, Vinay M D Prabhu, Nitin A R Rao","doi":"10.14701/ahbps.24-219","DOIUrl":"10.14701/ahbps.24-219","url":null,"abstract":"<p><strong>Backgrounds/aims: </strong>Assessing surgical difficulty in laparoscopic cholecystectomy (LC) is challenging due to variations in surgeon proficiency and institutional protocols. This study evaluates surgeons' perspectives on procedural difficulty and examines how intraoperative findings and preoperative imaging contribute to refining difficulty assessment criteria.</p><p><strong>Methods: </strong>A cross-sectional survey was conducted among 50 laparoscopic surgeons in India, providing insights into tolerances for surgical duration and blood loss, reasons for conversion, and predictors of complexity. Responses were analyzed using SPSS, with statistical significance set at <i>p</i> < 0.05.</p><p><strong>Results: </strong>Among surveyed surgeons, 82.0% were male, and 78.0% worked in private institutions and 52.0% had performed over 1,000 LCs. Conversion to open surgery was primarily influenced by significant blood loss (68.0%) and biliary injury (94.0%). While 38.0% preferred surgeries under 60 minutes, 26.0% imposed no time constraints. Key intraoperative challenges included dense adhesions, cholecysto-enteric fistulas, and fibrosis. Less experienced surgeons reported greater challenges with scarring adhesions and anatomical variations, but no significant differences were found for other factors like edematous or necrotic changes. Preoperative imaging was considered essential by most surgeons.</p><p><strong>Conclusions: </strong>This study underscores the limited reliability of traditional parameters for assessing difficulty in LC. Surgeons highlighted the importance of objective intraoperative findings and preoperative imaging in predicting surgical challenges. Factors such as adhesions, fibrosis, and anatomical variations significantly impact LC difficulty, with decisions regarding conversion to open surgery largely driven by individual judgment rather than experience. Standardized grading systems incorporating these factors could improve surgical planning, reduce complications, and enhance patient outcomes.</p>","PeriodicalId":72220,"journal":{"name":"Annals of hepato-biliary-pancreatic surgery","volume":" ","pages":"150-156"},"PeriodicalIF":1.1,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12093243/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143506051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Usefulness of intraoperative choledochoscopy in laparoscopic subtotal cholecystectomy for severe cholecystitis. 术中胆道镜在重度胆囊炎腹腔镜胆囊次全切除术中的应用。
IF 1.1 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-31 Epub Date: 2025-04-16 DOI: 10.14701/ahbps.25-010
Rui-Hui Zhang, Xiang-Nan Wang, Yue-Feng Ma, Xue-Qian Tang, Mei-Ju Lin, Li-Jun Shi, Jing-Yi Li, Hong-Wei Zhang

Laparoscopic subtotal cholecystectomy (LSC) has been a safe and viable alternative to conversion to laparotomy in cases of severe cholecystitis. The objective of this study is to determine the utility of intraoperative choledochoscopy in LSC for the exploration of the gallbladder, cyst duct, and subsequent stone clearance of the cystic duct in cases of severe cholecystitis. A total of 72 patients diagnosed with severe cholecystitis received choledochoscopy-assisted laparoscopic subtotal cholecystectomy (CALSC). A choledochoscopy was performed to explore the gallbladder cavity and/or cystic duct, and to extract stones using a range of techniques. The clinical records, including the operative records and outcomes, were subjected to analysis. No LSC was converted to open surgery, and no bile duct or vascular injuries were sustained. All stones within the cystic duct were removed by a combination of techniques, including high-frequency needle knife electrotomy, basket, and electrohydraulic lithotripsy. A follow-up examination revealed the absence of residual bile duct stones, with the exception of one common bile duct stone, which was extracted via endoscopic retrograde cholangiopancreatography. In certain special cases, CALSC may prove to be an efficacious treatment for the management of severe cholecystitis. This technique allows for optimal comprehension of the situation within the gallbladder cavity and cystic duct, facilitating the removal of stones from the cystic duct and reducing the residue of the non-functional gallbladder remnant.

腹腔镜胆囊次全切除术(LSC)是一种安全可行的替代转换为剖腹手术的情况下,严重的胆囊炎。本研究的目的是确定术中胆道镜在LSC中探查胆囊、囊肿管以及随后在严重胆囊炎病例中清除胆囊管结石的作用。共有72例诊断为严重胆囊炎的患者接受了胆道镜辅助腹腔镜胆囊次全切除术(CALSC)。行胆道镜探查胆囊腔和/或胆囊管,并使用一系列技术取出结石。分析临床记录,包括手术记录和结果。无一例LSC转为开腹手术,无胆管或血管损伤。所有囊管内结石均通过高频针刀电切开术、篮子和电液碎石等综合技术切除。随访检查显示,除经内窥镜逆行胆管造影取出一枚胆总管结石外,未见胆管结石残留。在某些特殊情况下,CALSC可能被证明是治疗严重胆囊炎的有效方法。该技术可以对胆囊腔和胆囊管内的情况进行最佳理解,促进胆囊管结石的清除,减少无功能胆囊残余的残留。
{"title":"Usefulness of intraoperative choledochoscopy in laparoscopic subtotal cholecystectomy for severe cholecystitis.","authors":"Rui-Hui Zhang, Xiang-Nan Wang, Yue-Feng Ma, Xue-Qian Tang, Mei-Ju Lin, Li-Jun Shi, Jing-Yi Li, Hong-Wei Zhang","doi":"10.14701/ahbps.25-010","DOIUrl":"10.14701/ahbps.25-010","url":null,"abstract":"<p><p>Laparoscopic subtotal cholecystectomy (LSC) has been a safe and viable alternative to conversion to laparotomy in cases of severe cholecystitis. The objective of this study is to determine the utility of intraoperative choledochoscopy in LSC for the exploration of the gallbladder, cyst duct, and subsequent stone clearance of the cystic duct in cases of severe cholecystitis. A total of 72 patients diagnosed with severe cholecystitis received choledochoscopy-assisted laparoscopic subtotal cholecystectomy (CALSC). A choledochoscopy was performed to explore the gallbladder cavity and/or cystic duct, and to extract stones using a range of techniques. The clinical records, including the operative records and outcomes, were subjected to analysis. No LSC was converted to open surgery, and no bile duct or vascular injuries were sustained. All stones within the cystic duct were removed by a combination of techniques, including high-frequency needle knife electrotomy, basket, and electrohydraulic lithotripsy. A follow-up examination revealed the absence of residual bile duct stones, with the exception of one common bile duct stone, which was extracted via endoscopic retrograde cholangiopancreatography. In certain special cases, CALSC may prove to be an efficacious treatment for the management of severe cholecystitis. This technique allows for optimal comprehension of the situation within the gallbladder cavity and cystic duct, facilitating the removal of stones from the cystic duct and reducing the residue of the non-functional gallbladder remnant.</p>","PeriodicalId":72220,"journal":{"name":"Annals of hepato-biliary-pancreatic surgery","volume":"29 2","pages":"192-198"},"PeriodicalIF":1.1,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12093239/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144063451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short-term and long-term outcomes of pancreas preserving total duodenectomy: A case series from a single center with 13 years' experience and complimentary meta-analysis. 保留胰腺的全十二指肠切除术的短期和长期结果:来自具有13年经验的单一中心的病例系列和补充荟萃分析。
IF 1.1 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-05-31 Epub Date: 2025-02-20 DOI: 10.14701/ahbps.24-214
Mohammed Hammoda, Shahab Hajibandeh, Bilal Al-Sarireh

Backgrounds/aims: To determine short-term and long-term outcomes after pancreas preserving total duodenectomy (PPTD).

Methods: A case series and a complementary meta-analysis were conducted. All patients with (pre)neoplastic lesions of duodenum who underwent PPTD in a tertiary center for pancreatic surgery between May 2009 and October 2022 were included for the case series. All studies in the literature with a sample size of 10 or more patients reporting outcomes of PPTD were included for the meta-analysis.

Results: A total of 439 patients (18 from case series and 421 from literature) were analyzed. Clavien-Dindo (CD) I complications in 2.9% (95% confidence interval [CI] 0.6%-5.2%), CD II complications in 21.1% (14.6%-27.6%), CD III complications in 18.1% (9.3%-26.9%), CD IV complications in 2.7% (0.5%-4.9%), and CD V complications in 2.2% (0.2%-4.2%) of patients were found. Probabilities of overall survival and recurrence-free survival at 15 years were 87% and 86%, respectively. There was no significant difference in the risk of mortality (odds ratio [OR]: 0.82, p = 0.830), total complications (OR: 0.77, p = 0.440), postoperative pancreatic fistula (OR: 0.43, p = 0.140), delayed gastric emptying (OR: 0.70, p = 0.450), or postoperative bleeding (OR: 0.97, p = 0.960) between PPTD and pancreaticoduodenectomy.

Conclusions: PPTD is safe and feasible for (pre)neoplastic lesions of duodenum not involving the pancreatic head. The risk of severe complications (CD > III) is low and long-term outcomes are favorable. Whether PPTD provides advantages over more radical techniques in terms of long-term outcomes remains controversial and requires further research.

背景/目的:探讨保胰全十二指肠切除术(PPTD)术后的短期和长期预后。方法:采用病例系列和补充性荟萃分析。2009年5月至2022年10月期间,所有在三级胰腺手术中心接受PPTD的十二指肠(前)肿瘤病变患者均被纳入病例系列。所有文献中样本量为10例或更多患者报告PPTD结果的研究均纳入meta分析。结果:共分析439例患者(18例来自病例系列,421例来自文献)。Clavien-Dindo (CD) I并发症发生率为2.9%(95%可信区间[CI] 0.6% ~ 5.2%), CD II并发症发生率为21.1% (14.6% ~ 27.6%),CD III并发症发生率为18.1% (9.3% ~ 26.9%),CD IV并发症发生率为2.7% (0.5% ~ 4.9%),CD V并发症发生率为2.2%(0.2% ~ 4.2%)。15年的总生存率和无复发生存率分别为87%和86%。在死亡率(优势比[OR]: 0.82, p = 0.830)、总并发症(OR: 0.77, p = 0.440)、术后胰瘘(OR: 0.43, p = 0.140)、胃排空延迟(OR: 0.70, p = 0.450)、术后出血(OR: 0.97, p = 0.960)方面,PPTD与胰十二指肠切除术的风险无显著差异。结论:PPTD治疗未累及胰头的十二指肠肿瘤前病变是安全可行的。严重并发症(CD > III)的风险较低,长期预后良好。就长期效果而言,PPTD是否优于更激进的技术仍存在争议,需要进一步研究。
{"title":"Short-term and long-term outcomes of pancreas preserving total duodenectomy: A case series from a single center with 13 years' experience and complimentary meta-analysis.","authors":"Mohammed Hammoda, Shahab Hajibandeh, Bilal Al-Sarireh","doi":"10.14701/ahbps.24-214","DOIUrl":"10.14701/ahbps.24-214","url":null,"abstract":"<p><strong>Backgrounds/aims: </strong>To determine short-term and long-term outcomes after pancreas preserving total duodenectomy (PPTD).</p><p><strong>Methods: </strong>A case series and a complementary meta-analysis were conducted. All patients with (pre)neoplastic lesions of duodenum who underwent PPTD in a tertiary center for pancreatic surgery between May 2009 and October 2022 were included for the case series. All studies in the literature with a sample size of 10 or more patients reporting outcomes of PPTD were included for the meta-analysis.</p><p><strong>Results: </strong>A total of 439 patients (18 from case series and 421 from literature) were analyzed. Clavien-Dindo (CD) I complications in 2.9% (95% confidence interval [CI] 0.6%-5.2%), CD II complications in 21.1% (14.6%-27.6%), CD III complications in 18.1% (9.3%-26.9%), CD IV complications in 2.7% (0.5%-4.9%), and CD V complications in 2.2% (0.2%-4.2%) of patients were found. Probabilities of overall survival and recurrence-free survival at 15 years were 87% and 86%, respectively. There was no significant difference in the risk of mortality (odds ratio [OR]: 0.82, <i>p</i> = 0.830), total complications (OR: 0.77, <i>p</i> = 0.440), postoperative pancreatic fistula (OR: 0.43, <i>p</i> = 0.140), delayed gastric emptying (OR: 0.70, <i>p</i> = 0.450), or postoperative bleeding (OR: 0.97, <i>p</i> = 0.960) between PPTD and pancreaticoduodenectomy.</p><p><strong>Conclusions: </strong>PPTD is safe and feasible for (pre)neoplastic lesions of duodenum not involving the pancreatic head. The risk of severe complications (CD > III) is low and long-term outcomes are favorable. Whether PPTD provides advantages over more radical techniques in terms of long-term outcomes remains controversial and requires further research.</p>","PeriodicalId":72220,"journal":{"name":"Annals of hepato-biliary-pancreatic surgery","volume":" ","pages":"157-167"},"PeriodicalIF":1.1,"publicationDate":"2025-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12093244/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143460882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of hepato-biliary-pancreatic surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1